LLNI Funded Publications
We are incredibly proud of every publication that LLNI funding has contributed to.
Publishing and sharing this information and data is integral to finding answers for the future.
Clarithromycin with low dose Dexamethasone and Thalidomide (CDT) is effective therapy in relapsed/refractory myeloma
Author:TCM Morris
Other Authors: PJ Kettle, M Drake, DR Hull, C Boyd, FCG Jones, A Morris, P Clarke, P O’Reilly, J Quinn,
Journal:Br J Haematol
Date: November 2008
Clearance of severe psoriasis after allogenic bone marrow transplantation.
Author:Bridges J M
Other Authors: Jones F G C,
Journal:Br. Med. J
Date: 1990
Clinical and haematological presentation of children and adolescents with polycythaemia vera.
Author:Holger C
Other Authors: McMullin MF, Pahl HL,
Journal:Annals of Hematology
Date: 2009
Clinical and molecular characterisation of a prospectively collected cohort of children and adolescents with polycythaemia vera
Author:Cario H
Other Authors: Schwarz K, Herter JM, Komrska V, McMullin MF, Minkov M, Niemeyer C, Pospisilova D, Reinhard D, Debatin KM, Pahl H,
Journal:British Journal for Haematology
Date: 2008
Clinical utility gene card for: familial erythrocytosis.
Author:Hussein K
Other Authors: Percy M, McMullin M F,
Journal:Eur J Hum Genet
Date: 2012
Clinical Utility of Microarray-Based Gene Expression Profiling in the Diagnosis and Subclassification of Leukemia: Report From the International Microarray Innovations in Leukemia Study Group.
Author:Haferlach T
Other Authors: Kohlmann A, Wieczorek L, Basso G, Kronnie G T, Bene M C, de Vos J, Hernandez J M, Hofmann W K, Mills K I, Gilkes A, Chiaretti S, Shurtleff S A, Kipps T J, Rassenti L Z, Yeoh A E, Papenhausen P R, Liu W M, Williams P M, Foa R,
Journal:Journal of Clinical Oncology
Date: 2010
Clonal diversity in the myeloproliferative neoplasms: independent origins of genetically distinct clones.
Author:Beer PA
Other Authors: Jones AV, Bench AJ, Goday-Fernandez A, Boyd EM, Vaghela KJ, Erber WN, Obeh B, Wright C, McMullin MF, Cullis J, Huntly BJP, Harrison CN, Cross CP, Green AR,
Journal:British Journal of Haematology
Date: 2009
Coexistence of inversion 16 in chronic myeloid leukaemia in blast crisis
Author:Catherwood M
Other Authors: McGrattan P, Lawless S, McConville C, Robson N, Lundy B, Humphreys M, Soverini S, Mills K, McMullin M,
Last Updated:22/10/2019
Source:CrossRef
Original Source:ORCID
Type:Journal Article
DOI:10.1007/s12308-016-0286-3
Journal:Journal of Hematopathology
Issue:4
Date: November 2016
Link:https://link.springer.com/article/10.1007/s12308-016-0286-3
Comparative Selectivity and Specificity of the Proteasome Inhibitors BzLLLCOCHO, PS-341 and MG-132
Author:L J A Crawford
Other Authors: Walker H, Ovaa D, Chauhan K, C Anderson, T C M Morris, A E Irvine,
Journal:Cancer Res
Date: 2006
Comparision of Lymphocyte-transfer test and white-blood-cell grouping for organ donor selection.
Author:Nelson S D
Other Authors: Bridges J M, McGeown M,
Journal:Lancet
Date: 1965
Complete array of HOX gene expression by RQ-PCR.
Author:Dickson GJ
Other Authors: Lappin TR, Thompson A,
Journal:Methods Mol Biol
Date: 2009
Compositional analysis gives insight into leukaemia cell lines expression profiles compared to those within patient sub-groups.
Author:Blayney JK
Other Authors: Mills KI,
Last Updated:22/10/2019
Source:PubMed
Original Source:PubMed
Type:Journal Article
DOI:10.1111/bjh.14711
Journal:British journal of haematology
Volume:181
Issue:6
Pages:847-851
Date: June 2018
Link:https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.14711
